Patent · US Active

Phospholipid analogs as diapeutic agents and methods thereof

US9550002B2 · kind B2 · utility

1Cited by
26References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 30, 2014
Grant dateJan 24, 2017
Priority date—
Expiry dateJul 23, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F13/005
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and uses of phospholipid ether analogs as diagnostic and therapeutic agents for numerous cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.